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journal homepage: www.urol-sci .comEditorial commentLaparoscopic radical prostatectomy is still a viable option for localized
prostate cancer in AsiansAlthough it has clearly been documented that there is a trend to-
ward robotic-assisted laparoscopic radical prostatectomy (RARP)
being the choice of treatment for localized prostate cancer, laparo-
scopic radical prostatectomy (LRP) is still a viable option for pros-
tate cancer patients in Asia.1 In 2009, 10.5% (13/123) prostate
cancer patients received LRP in all cases of radical prostatectomy
at one of Taiwan's referral medical centers.2 Transperitoneal (TP)
RARP and transperitoneal LRP (TLRP) provide a largeworking space
and clear anatomic exposure; these are adopted by the vast major-
ity of surgeons.3,4 Which approach is better when comparing the TP
with the retroperitoneal route? Randomized controlled trials are
needed to determine this. A meta-analysis of 942 cases from nine
controlled trials, including 492 cases of TLRP and 450 cases of
extraperitoneal laparoscopic radical prostatectomy (ELRP), was
analyzed.3 It was concluded that ELRP is similar to TLRPwith regard
to operation time, blood loss, and postoperative hospital stay, but
shorter postoperative intestinal function recovery was found with
ELRP.3
For the comparison of TP and extraperitoneal (EP) RARP, six con-
trol studies were reviewed.4 A total of 842 cases were enrolled, 530
patients for EP-RARP and 312 for TP-RARP. The ﬁndings suggested
that perioperative parameters, including operation time and hospi-
tal stay, may be more favorable for EP-RARP than for TP-RARP.4 The
oncologic outcome of margin positivity was similar.4 Ploussard
et al5 reported on a comparison 205 cases of ELRP and 83 cases of
EP RARP. Operating room time was not signiﬁcantly different be-
tween the two groups (223.6 minutes vs. 215.7 minutes in ELRP
vs. EP-RARP groups, p ¼ 0.23).5 The mean patient setup was longer
in the EP-RARP group (33.2 minutes vs. 24.0 minutes, p < 0.01).5
The mean operative time was signiﬁcantly shorter in the RARP
group (145.6 minutes vs. 164.7 minutes, p < 0.01).5 Hospital stay,
bladder catheterization, and complication rate were similar be-
tween the two groups.5
In this issue a small-scale study retrospectively compared 71
cases of ELRP and 22 cases of TLRP performed by a single surgeon
from 2006 to 2012.6 It concluded that ELRP has a shorter operation
time (184 minutes vs. 285 minutes, p < 0.05) and less blood loss
(183 mL vs. 276 mL, p < 0.05) than TLRP.6 The case number of
both groups was uneven, and there were only 22 cases in the
TLRP group. The surgeon performed, on average, four cases of
TLRP per year, and this means that there is still a learning curve
to be considered. However, the operator favored ELRP and per-
formed more cases using the four-trocar approach.6 The operator
(V.C. Lin) described this method with the following key steps for
ELRP: after the anterior bladder neck was open, an Endo Closehttp://dx.doi.org/10.1016/j.urols.2014.12.011
1879-5226/Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwneedle was used to pull the urethral Foley catheter upward to
make the posterior bladder neck prominent, and the needle was
used to perform a suprapubic small stabbing wound, sparing a
trocar.5 The 1-year continence rate was 100% in the ELRP group
and 95.5% in the TLRP group, and there was a 74% potency rate
for both groups.6 He concluded that the novel technique is a
feasible method for endoscopic laparoscopic radical prostatectomy
using four ports instead of ﬁve.6 ELRP has been proven to be a stan-
dardized and safe procedure with good oncologic and functional
outcomes at 5-year long-term follow-up.7 Verze et al7 published re-
sults about a total of 1600 consecutive ELRP cases. The mean oper-
ative time was 125.6 minutes (no pelvic lymph node dissection),
with an additional 25 minutes for bilateral pelvic lymph node
dissection.7 The positive surgical margin rates were 7.4% for pT2
and 13.4% for pT3 tumors.7 The overall complication rate was 4%.7
The 5-year biochemical recurrence-free survival (Prostate speciﬁc
antigen (PSA) < 0.2 ng/mL) after ELRP was 88.7% for patients staged
as pT2, 73.9% for pT3a, and 62.4% for pT3b.7 The complete urinary
continence rate was 92% after 12 months and 98.4% at 24-month
follow-up.7 The overall potency rate at 12-month follow-up was
75% for patients with bilateral neurovascular bundle preservation.7
This paper reﬂects the real-world situation of the role of LRP for
localized prostate cancer in Asia, if no da Vinci systems are available
in some hospitals. LRP has become the main tool for radical prosta-
tectomy, and this technique requires a degree of skill. Thus, several
surgeons have endeavored to modify and improve the technique
related to LRP, for example, by reducing the number of ports used
(use of 2- or single-port LRP in Asia).8e10 A Japanese medical center
described the surgical technique of an original EP two-port
approach for 22 cases of laparoendoscopic radical prostatectomy.8
A multichannel port with three 5-mm trocars and an additional
12-mm port were used. The operation was successfully completed
in all patients, but one patient required an additional 5-mm port to
control bleeding.8 The results showed that the operation time was
259 minutes and the ﬂuid loss (urine and blood) was 946 mL.8 No
intraoperative complications were noted, and the Foley indwelling
catheter was removed 6 days after surgery.8 Jiang et al10 reported
the midterm outcomes of 20 cases of laparoendoscopic single-site
radical prostatectomy with a homemade single-port device, with
a median follow-up of 22.8 months. The mean operative time
was 248 minutes, and the estimated blood loss was 94 mL.10 The
complication rate (Clavien Grade 2) was 20% (4/20).10 No biochem-
ical recurrence was detected. The complete continence rates were
85% and 90% at 1 year and 2 years, respectively.10 LRP is commonly
performed in Asia and Europe; preferably, a retroperitonealan LLC. Open access under CC BY-NC-ND license.
Editorial comment / Urological Science 26 (2015) 29e3030approach is used in several centers. Thus, it can be concluded that
LRP is feasible and safe, with excellent oncological and functional
outcomes.
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